Published in Curr Treat Options Gastroenterol on July 26, 2017
Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci (2000) 8.26
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol (2013) 7.81
The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe (2014) 7.43
Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis (2001) 6.92
Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis (2008) 6.21
Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology (2012) 6.04
Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ (2005) 5.59
Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med (2006) 5.10
Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med (2011) 4.62
Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc Natl Acad Sci U S A (2011) 4.53
Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol (2010) 4.52
Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis (2002) 4.13
Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol (2012) 3.84
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis (2012) 3.71
Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst (2003) 3.71
Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci U S A (2011) 3.55
Endoscopic perforation of the colon: lessons from a 10-year study. Am J Gastroenterol (2000) 3.52
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. Gastroenterology (2015) 3.12
Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut (2007) 3.09
Perforation during colonoscopy in endoscopic ambulatory surgical centers. Gastrointest Endosc (2003) 3.06
Risk of perforation from a colonoscopy in adults: a large population-based study. Gastrointest Endosc (2009) 2.78
The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology (2014) 2.73
Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med (2001) 2.65
Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol (2014) 2.65
A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol (2008) 2.57
Colonoscopy: a prospective report of complications. J Clin Gastroenterol (1992) 2.54
Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology (2008) 2.52
Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate. Aliment Pharmacol Ther (2015) 2.15
Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther (2012) 2.11
Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis (2009) 2.03
Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-activated cell sorting and 16S rRNA gene analysis. Appl Environ Microbiol (2005) 1.74
Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther (2010) 1.73
Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease. Ann Surg (2011) 1.68
Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease. Aliment Pharmacol Ther (2011) 1.67
Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc (2005) 1.54
Adverse events in faecal microbiota transplant: a review of the literature. J Hosp Infect (2015) 1.53
Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.41
Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. Gastroenterology (2004) 1.38
The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu Rev Med (2015) 1.33
From stool transplants to next-generation microbiota therapeutics. Gastroenterology (2014) 1.29
Complications of colonoscopy and polypectomy. Surg Clin North Am (1982) 1.25
Age related changes in gut physiology and nutritional status. Gut (1996) 1.21
Inflammatory bowel disease of the elderly: frequently asked questions (FAQs). Am J Gastroenterol (2011) 1.20
Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2013) 1.20
Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease. J Crohns Colitis (2015) 1.15
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther (2015) 1.15
Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol (1996) 1.12
Epidemiology of Clostridium difficile infection. J Pharm Pract (2013) 1.10
Crohn's disease in the elderly: a comparison with young adults. J Clin Gastroenterol (1998) 1.05
Clostridium difficile infection in the elderly. Clin Geriatr Med (2014) 1.05
Colonoscopy in elderly people is a safe procedure with a high diagnostic yield: a prospective comparative study of 2000 patients. Endoscopy (2006) 1.03
Age-related clinical severity at diagnosis in 1705 patients with ulcerative colitis: a study by GISC (Italian Colon-Rectum Study Group). Dig Dis Sci (2000) 1.03
Understanding the mechanisms of faecal microbiota transplantation. Nat Rev Gastroenterol Hepatol (2016) 1.01
Fecal transplantation for recurrent Clostridium difficile infection in older adults: a review. J Am Geriatr Soc (2013) 1.00
Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2016) 0.98
Early and late onset ulcerative colitis: distinct clinical features. J Clin Gastroenterol (1985) 0.97
Risk factors for colonoscopic perforation: a population-based study of 80118 cases. World J Gastroenterol (2013) 0.96
Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection. BMC Med (2016) 0.95
Age as a risk factor in colonoscopy: fact versus fiction. Am J Gastroenterol (1988) 0.94
Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience. J Clin Gastroenterol (2016) 0.93
The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals. J Clin Gastroenterol (2016) 0.92
Colonoscopy in patients 80 years of age and older is safe, with high success rate and diagnostic yield. Gastrointest Endosc (2004) 0.92
Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives. Clin Endosc (2016) 0.90
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes. Dig Dis Sci (2016) 0.88
Transfer of Viral Communities between Human Individuals during Fecal Microbiota Transplantation. MBio (2016) 0.88
Emergence of fecal microbiota transplantation as an approach to repair disrupted microbial gut ecology. Immunol Lett (2014) 0.88
Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease. Inflamm Bowel Dis (2016) 0.87
The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease. Dig Dis Sci (2014) 0.86
A multicenter study of Clostridium difficile infection-related colectomy, 2000-2006. Infect Control Hosp Epidemiol (2012) 0.85
Gut microbiota and obesity. Cell Mol Life Sci (2015) 0.85
Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection. Aliment Pharmacol Ther (2015) 0.84
Fecal microbiota transplantation for patients with steroid-resistant/dependent acute graft-versus-host disease of the gut. Blood (2016) 0.81
Fecal Microbiota Transplantation Using Upper Gastrointestinal Tract for the Treatment of Refractory or Severe Complicated Clostridium difficile Infection in Elderly Patients in Poor Medical Condition: The First Study in an Asian Country. Gastroenterol Res Pract (2016) 0.81
The AGA's Fecal Microbiota Transplantation National Registry: An Important Step Toward Understanding Risks and Benefits of Microbiota Therapeutics. Gastroenterology (2017) 0.80
The therapeutic potential of antibiotics and probiotics in the treatment of pouchitis. Expert Rev Gastroenterol Hepatol (2015) 0.78
Structure and functions of the gut microbiome. Endocr Metab Immune Disord Drug Targets (2014) 0.77
Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State. J Alzheimers Dis (2016) 0.77
Decrease in Surgery for Clostridium difficile Infection After Starting a Program to Transplant Fecal Microbiota. Ann Intern Med (2015) 0.75
Fecal Microbiota Transfer in Patients With Chronic Antibiotic-Refractory Pouchitis. Am J Gastroenterol (2016) 0.75